Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

S. Schneider, Lon; N. Tariot, Pierre; Dagerman, Karen; M. Davis, Sonia; Hsiao, John; Saleem Ismail, M.; D. Lebowitz, Barry; G. Lyketsos, Constantine; Michael Ryan, J.; Scott Stroup, T.; L. Sultzer, David; Weintraub, Daniel; A. Lieberman, Jeffrey

doi:10.1056/nejmoa061240

Public

Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

Published in New England Journal of Medicine • Oct 11, 2006

Authors:

Lon S. Schneider

Pierre N. Tariot

Karen Dagerman

Abstract

BACKGROUND: Second-generation (atypical) antipsychotic drugs are widely used to treat psychosis, aggression, and agitation in patients with Alzheimer's disease, but their benefits are uncertain and concerns about safety have emerged. We assessed the effectiveness of atypical antipsychotic drugs in o...

Subject

Olanzapine

Discontinuation

Quetiapine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!